Neurocysticercosis: Neglected but not forgotten

PLoS Neglected Tropical Diseases

Volumn 6, Issue 5, 2012, Pages

  Coyle, Christina M ^a   Mahanty, Siddhartha ^b   Zunt, Joseph R ^c   Wallin, Mitchell T ^d,e   Cantey, Paul T ^f   White, A Clinton ^g   O'Neal, Seth E ^h   Serpa, Jose A ⁱ   Southern, Paul M ^j   Wilkins, Patricia ^f   McCarthy, Anne E ^k   Higgs, Elizabeth S ^b   Nash, Theodore E ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g University of Texas Medical Branch School of Medicine   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CHINA; COMPUTER ASSISTED TOMOGRAPHY; ENDEMIC DISEASE; EPILEPSY; HUMAN; INDIA; NEUROCYSTICERCOSIS; PARASITE LOAD; SEROLOGY; SEROPREVALENCE; SOUTH AND CENTRAL AMERICA; TAENIA SOLIUM; TAENIASIS; HEALTH; NEGLECTED DISEASE; PREVALENCE; REVIEW;

HUMANS; NEGLECTED DISEASES; NEUROCYSTICERCOSIS; PREVALENCE; WORLD HEALTH;

EID: 84863647720     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001500     Document Type: Article

References (31)

1. Wallin MT, Kurtzke JF, (2004) Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63: 1559-1564.
2. Savioli LS, Daumerie D, (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases Geneva World Health Organisation pp. 1-169 2010.1 2010.1.
3. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300 doi:10.1371/journal.pntd.0000300.
4. Winkler AS, Willingham AL 3rd, Sikasunge CS, Schmutzhard E, (2009) Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr 121 (Suppl 3): 3-12.
5. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
6. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A, (2004) Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg 98: 478-484.
7. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, et al. (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65: 229-233.
8. Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, et al. (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583-587.
9. Medina MT, Duron RM, Martinez L, Osorio JR, Estrada AL, et al. (2005) Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 46: 124-131.
10. Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, et al. (2003) High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 22: 139-145.
11. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, et al. (1999) Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29: 1203-1209.
12. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J, (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67: 2135-2139.
13. Zoli AP, Nguekam, Shey-Njila O, Nsame Nforninwe D, Speybroeck N, et al. (2003) Neurocysticercosis and epilepsy in Cameroon. Trans R Soc Trop Med Hyg 97: 683-686.
14. Prado-Jean A, Kanobana K, Druet-Cabanac M, Nsengyiumva G, Dorny P, et al. (2007) Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi. Trop Med Int Health 12: 895-901.
15. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, et al. (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870 doi:10.1371/journal.pntd.0000870.
16. del la Garza Y, Graviss EA, Daver NG, Gambarin KJ, Shandera WX, et al. (2005) Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg 73: 766-770.
17. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, et al. (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608-613.
18. Townes JM, Hoffmann CJ, Kohn MA, (2004) Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis 10: 508-510.
19. Sorvillo FJ, Waterman SH, Richards FO, Schantz PM, (1992) Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. Am J Trop Med Hyg 47: 365-371.
20. Dumas M, Grunitzky E, Deniau M, Dabis F, Bouteille B, et al. (1989) Epidemiological study of neuro-cysticercosis in northern Togo (West Africa). Acta Leidensia 57: 191-196.
21. Zoli A, Shey-Njila O, Assana E, Nguekam JP, Dorny P, et al. (2003) Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop 87: 35-42.
22. Avode DG, Bouteille B, Houngbe F, Adjien C, Adjide C, et al. (1998) Epilepsy, cysticercosis and neurocysticercosis in Benin. Eur Neurol 39: 60-61.
23. Houinato D, Ramanankandrasana B, Adjide C, Melaku Z, Josse R, et al. (1998) Seroprevalence of cysticercosis in Benin. Trans R Soc Trop Med Hyg 92: 621-624.
24. Nguekam JP, Zoli AP, Zogo PO, Kamga AC, Speybroeck N, et al. (2003) A seroepidemiological study of human cysticercosis in West Cameroon. Trop Med Int Health 8: 144-149.
25. Kanobana K, Praet N, Kabwe C, Dorny P, Lukanu P, et al. (2011) High prevalence of Taenia solium cysticerosis in a village community of Bas-Congo, Democratic Republic of Congo. Int J Parasitol 41: 1015-1018.
26. Secka A, Grimm F, Marcotty T, Geysen D, Niang AM, et al. (2011) Old focus of cysticercosis in a senegalese village revisited after half a century. Acta Trop 119: 199-202.
27. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2009) Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 50: 987-993.
28. Vilhena M, Santos M, Torgal J, (1999) Seroprevalence of human cysticercosis in Maputo, Mozambique. Am J Trop Med Hyg 61: 59-62.
29. Foyaca-Sibat H, Cowan LD, Carabin H, Targonska I, Anwary MA, et al. (2009) Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. PLoS Negl Trop Dis 3: e562 doi:10.1371/journal.pntd.0000562.
30. Mason P, Houston S, Gwanzura L, (1992) Neurocysticercosis: experience with diagnosis by ELISA serology and computerised tomography in Zimbabwe. The Central African Journal of Medicine 38: 149-154.
31. Flisser A, Gyorkos TW, (2007) Contribution of immunodiagnostic tests to epidemiological/intervention studies of cysticercosis/taeniosis in Mexico. Parasite Immunol 29: 637-649.